Literature DB >> 8402152

Expression of neuropeptide processing enzymes and neurosecretory proteins in ependyma and choroid plexus epithelium.

P Gee1, C H Rhodes, L D Fricker, R H Angeletti.   

Abstract

Recent studies suggest that brain ependyma and choroid plexus produce neuropeptide processing enzymes. To facilitate the understanding of these cells and their ability to produce biologically active peptides, we developed cultures of defined cell type. Ependymal cells were characterized by morphological criteria, and choroid plexus epithelial cell lines were characterized by the presence of the mRNA for IGF-II and transthyretin, a thyroxine binding protein produced in liver and choroid plexus. The ependymal cells and the choroid plexus epithelial cell lines were then examined for the presence of mRNAs for various neuropeptide processing enzymes. Northern blot analysis revealed high levels of furin, carboxypeptidase E, and peptidyl glycine alpha-amidating monooxygenase mRNAs, with levels in ependymal cells comparable to those in brain or pituitary. Carboxypeptidase E activity was detected in medium from cultured ependymal cells; this activity was identified as carboxypeptidase E based on the acidic pH optimum and sensitivity to various inhibitors. The mRNAs for other neuropeptide processing enzymes, such as prohormone convertases 1 and 2, were not detected on Northern blots of RNA from ependyma or choroid plexus epithelium. Since ependyma and choroid plexus epithelium express a subset of processing enzymes, we suggest that these cells have the capacity to produce biologically active peptides. Initial screening by reverse transcriptase-polymerase chain reaction assays has demonstrated the presence of mRNA for the neurosecretory proteins chromogranin B and secretogranin II in both ependyma and choroid plexus epithelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8402152     DOI: 10.1016/0006-8993(93)91091-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Genetic approach for intracerebroventricular delivery.

Authors:  Limor Regev; Eli Ezrielev; Eran Gershon; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

2.  Dorsal border periaqueductal gray neurons project to the area directly adjacent to the central canal ependyma of the C4-T8 spinal cord in the cat.

Authors:  L J Mouton; L Kerstens; J Van der Want; G Holstege
Journal:  Exp Brain Res       Date:  1996-11       Impact factor: 1.972

3.  Processing of proSAAS in neuroendocrine cell lines.

Authors:  Nino Mzhavia; Yimei Qian; Yun Feng; Fa-Yun Che; Lakshmi A Devi; Lloyd D Fricker
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

4.  Primary culture of choroidal epithelial cells: characterization of an in vitro model of blood-CSF barrier.

Authors:  W Zheng; Q Zhao; J H Graziano
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

Review 5.  Synthesis, Quantification, and Characterization of Fatty Acid Amides from In Vitro and In Vivo Sources.

Authors:  Ruidong Ni; Suzeeta Bhandari; Perry R Mitchell; Gabriela Suarez; Neel B Patel; Kara Lamb; Kirpal S Bisht; David J Merkler
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

Review 6.  In Vitro Models of the Blood-Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals.

Authors:  Fatemeh Dabbagh; Horst Schroten; Christian Schwerk
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.